Navigation Links
IPO in Biological Technology

Sucampo Pharmaceuticals Announces Exercise and Closing of IPO Over-Allotment Option

BETHESDA, Md., Aug. 29 /PRNewswire-FirstCall/ -- Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP ) today announced that the underwriters for its initial public offering have exercised in full their option to purchase 562,500 shares of Sucampo's class A common stock to cover over-allotments and th...

The IPO Window Cracks

SAN MATEO, CA - With the children now back in school and a general air of a "new year" upon us, we have the opportunity to demonstrate that the grownups have learned a few lessons from the pain of the economic crunch. Over the next few weeks, a number of courageous souls will take their compani...

TomoTherapy considers IPO with medical-device business on the rise

A technology that could bring better, safer treatments to cancer patients worldwide might have fallen through the cracks. Now Tomotherapy, a Madison medical-device firm with more than 200 employees that has grown to $44 million in sales, could go public within a year, its founder said. The compa...

Though Weakening, Biotech IPO Market Still Viable, Burril & Co. Says

CHICAGO Anyone following this column over the last few years knows about my propensity for lists. These lists allow me to arrange information into tidy boxes in some meaningful order for others (or at least to make better sense out of the information for myself). While my list propensity didn...

TomoTherapy revises IPO money target

Madison, Wis . - TomoTherapy has filed an amended registration statement with the U.S. Securities and Exchange Commission , raising to $213 million the amount it could raise in its pending initial pubic offering of stock. While there is still no date for the IPO, the company expected the o...

NimbleGen to discontinue IPO after Roche's $272.5 million acquisition

Madison, Wis. - NimbleGen Systems , a manufacturer of gene chips for pharmaceutical research, will discontinue its work toward an initial public offering of stock following its acquisition by Roche , the Basel, Switzerland based pharmaceutical giant. NimbleGen had sought to raise $75 million...

Cash-rich TomoTherapy has no plans for IPO

Madison, Wis. - TomoTherapy, Inc. , the medical device developer that has secured $42 million in outside equity and has rapidly grown sales of its precision radiation therapy technology based on the innovations of University of Wisconsin-Madison researchers, is riding high. So high that it ...

TomoTherapy files registration statement for IPO

Madison, Wis. - TomoTherapy, Inc. has filed a registration statement with the Securities and Exchange Commission for an initial public offering of common stock. The Madison-based medical device manufacturer has filed a Form S-1 to sell shares on the NASDAQ Global Market . The number ...

TomoTherapy raises $223 million in IPO

Madison, Wis .- TomoTherapy has raised $223 million, the amount it had hoped to raise, in an initial public offering that was completed earlier today. TomoTherapy, a portfolio company of Baird Venture Partners I , offered common stock at $19 per share, and expects to receive $185 million in ...

Burrill & Company Invests in Taiwan Liposome Company

...ence Venture Corp., and other earlier investors. The proceeds will serve to advance the development of its lead product and prepare the company for an ipo in Taiwan. About Taiwan Liposome Company Incorporated in 1997, Taiwan Liposome Company is a biopharmaceutical company engaging in research, dev...

Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young

...time. Capital raised declined sharply in 2008. Companies in the Americas and Europe raised US$16 billion in 2008, a 46% decline from 2007. ipo funding fell 95% to US$116 million. Biotech venture financing remained relatively strong, falling only 19% from 2007's all-time record to ...

Horizon Therapeutics Selected to Present at InsideVenture's Debut Investor Conference March 25-26, Santa Barbara, California

...nnect the best late-stage venture-backed companies with revered long-term institutional and strategic investors to facilitate late-stage transactions, ipo participation and aftermarket support. InsideVenture is supported by investment leaders and partners like T. Rowe Price, Wasatch Advisors, SVB Financi...

Mindray Appoints Mr. Ronald Ede as Chief Financial Officer

...ortant phase of its growth, we believe Ronnie is exceptionally qualified to take on the CFO position given his familiarity with the business since the ipo both in the capacity of an independent director and subsequently a member of the senior management team," commented Mr. Li Xiting, Mindray's President...

Sinobiomed Announces New Executive Team

...in the near future. A former partner with Deloitte Touche Tohmatsu, Mr. Choong has 20 years of experience in corporate finance, business development, ipo and M&A, and financial management and reporting in a variety of industries in Hong Kong, China and overseas, most recently as head of corporate fi...

Volatile Economy / Fundraising Challenges Encourage Business Combinations Among Biotech Companies According to New Survey from CPA Firm Rothstein Kass

...e industry will diminish "The need for biotech firms to pursue strategic alliances will be heightened by continuing weakness in U.S. ipo markets. For many private equity and venture capital investors, taking a portfolio company public has been the optimal exit strategy. However, given c...

AMT CEO Ronald Lorijn Steps Down

...pipeline and lead product Glybera(R). The Company reached within four years a number of key milestones: successful financing round in 2006; successful ipo in 2007; multiple R&D strategic international collaborations; and Glybera(R) close to filing for marketing approval in Europe, USA and Canada. ...

Interim Report for the Period 1 January - 30 September 2008 (Unaudited)

...lion in the first nine months of 2008 compared to a net cash inflow of DKK 338.4 million in the same period of 2007. The decrease is mainly due to the ipo in the third quarter of 2007 but is also due to higher operating costs compared to last year. As of 30 September 2008, cash and cash equivalen...

Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloitte's 2008 Technology Fast 500

... accompanied by members of the Company's executive management team. The event is to mark the first year of operation as a public company following its ipo in November of 2007. Founded in 1999, Genoptix has been profitable since the first quarter of 2007 and has delivered 17 consecutive quarters of soli...

BSP Signs Agreement With CMP Trading for Distribution of HyperQ(TM) Stress System, for Early Detection of Ischemic Heart Disease, in South Korea

... the diagnosis and monitoring of Ischemic Heart Disease. BSP was founded in 2000 by Dr. Amir Beker and Mr. Ariel Landau and has completed a successful ipo in mid-2006 and its shares are traded on the Tel Aviv Stock Exchange. Contacts: Dr. Amir Beker, CEO Dr. Neri Malka, Head of Clinical Marketing ...

ThromboGenics N.V.: Business Update

...n indices by Euronext. The elevation of ThromboGenics to the Bel Mid Index reflects the significant progress that the Company has made since its ipo in 2006. Corporate Update - On 1 September, Patrik De Haes, MD, formerly the Company's Chief Operating Officer, was appointed to succeed Pr...

Replidyne and Cardiovascular Systems Sign Merger Agreement

...drew its registration statement for the initial public offering today. According to Martin, "The current equity market conditions have resulted in the ipo market coming to a standstill. Given the uncertainty regarding timing of a market recovery, we believe that this transaction offers the best opportuni...

Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer

...id Timothy P. Walbert, president and chief executive officer. "During his career, Bob has been instrumental in numerous M&A transactions as well as an ipo and will be an important part of Horizon's future growth." Mr. De Vaere's most recent position was as senior vice president, finance and administrat...

Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets

...ver 2006. The average valuation at the time of the ipo swelled to US$405 million, a 94% increase over 2006. -- ipo performance. Eight out of the 13 medtech companies...t went public in 2007 saw gains from their initial ipo valuations during the year, which led to an averag...

ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer

...e has made a major contribution to the building of ThromboGenics' exciting development pipeline, as well as leading the Company through its successful ipo on Euronext Brussels in June 2006. Dr. Patrik De Haes, commenting on his appointment said, "I am very pleased to have been appointed as the CEO of T...

Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer

...Inc., one of the largest biotech acquisitions of 2007; Advanced BioHealing, a leader in regenerative medicine; and Dexcom Inc., the largest diagnostic ipo of 2005. Other Canaan healthcare investments include Amicus Therapeutics, Chimerix, Inc., ReVision Optics, Inc., and Transoma Medical, Inc. Canaan has...

DNA Heritage Success in Patent Battle Helps Keep Genealogy DNA Test Prices Low

... infringement challenge from patent assignees Oxford Ancestors, which had been running for over two years, was thwarted when DNA Heritage asked the UK ipo to re-evaluate the patent claims in the light of work by previous researchers. After considering submissions from both parties, an Opinion provided on...

Gerresheimer Further Increases its Sales and Earnings Power

...rgin to around 19.5 %. The sound balance sheet structure and equity ratio combined with the significant reduction in financial liabilities after the ipo in 2007 plus the cash flow generated will in the future enable Gerresheimer to achieve further organic growth and successfully continue its strategy o...

TechCFO Adds Two New Partners to Atlanta Office

... positioned companies for mergers with large competitors. He has also played an instrumental role in a $2 billion capital restructuring and subsequent ipo and acquisition of over $1.5 billion of operating properties for New World Communications. Froistad is a Certified Public Accountant (CPA) and earned ...

Pharmasset Joins Russell 3000 Index

...ecame publicly traded," stated Kurt Leutzinger, Pharmasset's Chief Financial Officer. "We feel fortunate that our stock price has grown 117% since the ipo in an otherwise difficult market." About Pharmasset Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and...

FierceBiotech Names NanoBio Corporation as One of the 'Fierce 15' Biotech Companies of 2008

...that vaccines are developed and manufactured. The data look promising, a phase III looms, partnerships beckon, and then there's the lure of a possible ipo in the not-too-distant future. For a nano-bio company, NanoBio is well ahead of the pack." NanoBio's lead treatments are topical lotions for cold so...

IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008

...or Non-GAAP Financial Measures The Company's Board of Directors approved one-time bonuses paid in the first quarter of 2008 related to the Company's ipo of $0.3 million, which decreased the Company's pro-forma fully diluted earnings per share for the first quarter of 2008 by $0.01. IPC computes its adj...

BSP Raises $2.6 Million Dollars From Private Investors

... the diagnosis and monitoring of Ischemic Heart Disease. BSP was founded in 2000 by Dr. Amir Beker and Mr. Ariel Landau and has completed a successful ipo in mid-2006 and its shares are traded on the Tel Aviv Stock Exchange. Visit: http://www.bspmedical.com Contact: Dr. Amir Beker, CEO or Dr. Neri Ma...

WuXi PharmaTech Announces First Quarter 2008 Results

...ur belief that our cash flows will remain healthy and alternative financing options, if required to meet our funding needs, are available. Since our ipo in August 2007, our officers and directors have been unable to sell shares due to underwriter-related lock-ups (including lock-ups previously entered ...

Bioheart, Inc. Announces Financial Results for First Quarter 2008

...y completed its initial public offering (IPO) of common stock for gross proceeds of approximately $5.8 million. The net cash proceeds from the ipo are expected to be utilized to commence full-scale enrollment in a Phase II/III MARVEL Clinical Trial of MyoCell(R) in the U.S. and Europe. ...

3SBio Inc. Announces First Quarter 2008 Results

..., as compared to net other income of RMB6.4 million in the first quarter 2007, as a result of increased interest income from the net proceeds from our ipo in February 2007. No interest expense was incurred in the first quarter 2008 as compared to RMB0.4 million in first quarter 2007. Income before Inco...

Northwest Secures US$4.0 Million in Debt Financing

...essment. Alton L. Boynton, Chief Executive Officer of NWBT said: "We are delighted to have secured this Loan from Al Rajhi. Since investing in our ipo on AIM in June 2007, Al Rajhi has accumulated a significant stake in Northwest and currently holds in excess of ten per cent of our issued and outstan...

Thermage Announces First Quarter 2008 Financial Results

...s well as complementary acquisitions that add value for our customers and shareholders," continued Mr. Fanning. "One of the primary reasons behind our ipo was to raise funds that would allow us to pursue this strategy. During the first quarter, we reached an advanced stage of negotiations with a potentia...

Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer

...ance and Administration and Chief Financial Officer of Nucryst Pharmaceuticals (Nasdaq: NCST, TSX: NCS), where he successfully completed a $45 million ipo within 6 months of joining the company and was responsible for SEC reporting and the implementation of Sarbanes-Oxley requirements. Previously, he ser...

Biotech Avoids Fall Out From Tough Quarter for Capital Markets

... The tough economic environment kept other biotech ipo "hopefuls" grounded on the runway. Several, however, did file for an ipo in order to get in line and be ready to respond rapidly to complete their ipo when the market improves: -- Bayhill Therapeut...

ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007

...om $7.7 million for the full year 2006. This decrease was principally a result of legal and consulting expenses capitalized upon the completion of the ipo in 2007 compared to costs related to the unsuccessful IPO attempt in 2006 that were expensed. On December 31, 2007, ImaRx had $12.9 million in cash,...
Other Tags
(Date:10/15/2014)... Lithuania , Oct. 15, 2014   ... technologies, today announced the availability of the ... VeriLook Surveillance 3.0 provides real-time biometric face identification ... high-resolution digital surveillance cameras. The new version not ... and differentiates people from objects while they are ...
(Date:10/14/2014)... Research shows SIRT6—a protein known to inhibit the ... of skin cancers by turning on an enzyme that ... , Previously considered protective, SIRT6 is part of a ... genomic stability and prevent some of the genetic flaws ... can lead to cancer. This study, in the journal,s ...
(Date:10/14/2014)... N.Y. – Scientists have sequenced the house fly genome ... one might expect from an insect that thrives in ... published Oct. 14 in the journal Genome Biology ... biology and of how flies quickly adapt to resist ... Adult house flies (Musca domestica) carry and transmit more ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2House fly genome reveals expanded immune system 2
(Date:10/22/2014)... Although there are only 24 hours in a ... who have trouble finding time within their busy schedules for exercise ... periods of time to get in shape. Here are five ways ... go. , Change Up Your Commute , Consider riding a ... some exercise into your daily routine. If you must use your ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... A crucial part of conventional in vitro fertilization (IVF) -- ... instead take place in a device inside the vagina, new ... contend that the device, called an INVOcell, might sharply cut ... also make the technology more accessible to those who don,t ...
(Date:10/20/2014)... The newly updated Worldwide Medical Market Forecasts ... facts, figures and forecasts on the global medical markets. ... categories the Worldwide Medical Market Forecasts to 2019 ... on the worldwide medical market to reveal key insights ... data for 2010-2019, covering each country market individually, allowing ...
(Date:10/20/2014)... ASCNYC (ascnyc.org) is a New ... Yorkers living with HIV/AIDS and other chronic conditions ... and self-sufficiency. Each year, ASCNYC spotlights selected “Positive ... their tireless efforts. , Savills Studley ... been selected as this year’s honoree for sharing ...
Breaking Medicine News(10 mins):Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3
Other Contents